GRUPO DE GESTANTES E CASAIS GRÁVIDOS: PARCERIA DO DEPARTAMENTO DE ENFERMAGEM E HOSPITAL UNIVERSITÁRIO/ UFSC

Relato de experiência sobre as atividades desenvolvidas no grupo de Gestantes e Casais Grávidos. È um projeto de extensão, gratuito e educativo, realizado desde de 1996, dirigido às gestantes e acompanhantes. Coordenado por docentes do Departamento de Enfermagem da Universidade Federal de Santa Catarina, psicóloga do Hospital Universitário e educadora perinatal. Os encontros de cada grupo são realizados semanalmente no Núcleo de Capacitação Técnica durante oito semanas, sendo constituídos de três grandes momentos: conscientização corporal, relaxamento e respiração, lanche e tematização. Os temas são definidos pelos participantes abrangem a gravidez, o aleitamento, a alimentação, parto, pós-parto, cuidados com o bebê e formação da nova família. Esses e os subtemas que divergem em cada grupo são refletidos e problematizados coletivamente. No último encontro é realizada a visita à maternidade. Nesses 17 anos, 68 grupos foram realizados, com a presença de 1294 gestantes, 751 acompanhantes, alunos de graduação de enfermagem, psicologia, odontologia, de educação física, mestrandas de enfermagem e profissionais de saúde. O Grupo de Gestantes tem sido um campo de formação acadêmica, sendo um espaço para o ensino-aprendizagem. Busca, sobretudo, ampliar o espaço de troca, de interação e de comunicação com a com as gestantes e s acompanhantes, para que possam melhor compreender o processo de nascimento e o papel da mulher e do homem como protagonistas da gestação, parto e pós-parto, preparando-os para a maternidade e paternidade

Genotyping of South American clinical isolates of Pythium insidiosum based on single nucleotide polymorphism-based multiplex PCR

We aimed to genotype the South American clinical isolates of Pythium insidiosum using the single nucleotide polymorphisms (SNP) of the ribosomal DNA sequences (rDNA). Previously, an SNP-based multiplex-PCR was able to distinguish three different clades of P. insidiosum isolates. Thus, we used this assay to evaluate South American clinical isolates of P. insidiosum (n=32), standard strains from Costa Rica (n=4), Thailand (n=3), Japan (n=1), and India (n=1), a standard strain of Pythium aphanidermatum, and Brazilian environmental isolates of Pythium torulosum, Pythium rhizo-oryzae and Pythium pachycaule voucher (n=3). It was possible to allocate each American P. insidiosum isolate to clade I, the isolates of India, Japan, and Thailand to clade II, and the Thai isolate to clade III. P. aphanidermatum, P.torulosum, P.rhizo-oryzae and P.pachycaule voucher isolates were not amplified. For the first time, a P. insidiosum isolate from Uruguay, South America, was included in molecular analyzes. By SNP-based multiplex-PCR, it was possible to perform the identification and genotyping of the South American isolates of P. insidiosum, demonstrating similar genetic characteristics of these isolates. Key words: Pythium insidiosum, Pythiosis, molecular detection, genotype, single nucleotide polimorphisms.O objetivo deste estudo foi genotipar isolados clínicos de Pythium insidiosum da América do Sul utilizando polimorfismos de nucleotídeo único (SNP) de sequências de rDNA. Anteriormente, um multiplex-PCR baseado em SNP foi capaz de distinguir P. insidiosum em três diferentes clados. Dessa forma, utilizamos este método para avaliar isolados clínicos de P. insidiosum da América do Sul (n=32), cepas padrão da Costa Rica (n=4), Tailândia (n=3), Japão (n=1) e Índia (n=1), uma cepa padrão de Pythium aphanidermatum e isolados ambientais brasileiros de Pythium torulosum; Pythium rhizo-oryzae e Pythium pachycaule voucher (n=3). Os isolados analisados foram alocados aos clados: I (americanos), II (isolados da Índia, Japão e Tailândia), e III (um isolado tailandês). P. aphanidermatum, P.torulosum, P.rhizo-oryzae e P.pachycaule voucher não foram amplificados. Pela primeira vez, um isolado de P. insidiosum do Uruguai foi incluído em análises moleculares. Através da multiplex-PCR baseada em SNP, foi possível realizar a identificação e genotipagem dos isolados sulamericanos de P. insidiosum, demonstrando características genéticas semelhantes entre esses isolados

Atividade antimicrobiana do extrato bruto de Açaí (Euterpe oleracea Mart.) em isolados clínicos

O presente trabalho teve como objetivo avaliar a atividade antimicrobiana do extrato de açaí (Euterpe Oleracea Mart.) em isolados clínicos com elevados perfis de resistência a diferentes antimicrobianos provenientes do Centro Hospitalar de Trás – os – Montes e Alto Douro – Unidade de Vila Real. A concentração mínima inibitória (CMI) foi determinada utilizando o ensaio colorimétrico rápido que utiliza o corante cloreto de p-iodonitrotetrazólio (INT) após já ter sido efetuado o método da microdiluição. De acordo com os resultados obtidos, o extrato bruto de açaí possui atividade antimicrobiana para todas as bactérias Gram positivo testadas. A CMI mais baixa (0,25 mg/ml) foi detectada para Staphylococcus aureus sensível à meticilina (MSSA) seguida da CMI 0,5 mg/ml para Staphylococcus aureus resistente à meticilina (MRSA), Streptococcus agalactiae e Enterococcus faecalis. Relativamente às bactérias Gram negativo foi verificada atividade antimicrobiana do açai para Morganella morganii, Pseudomonas aeruginosa e Acinetobacter baumannii com CMI de 1 mg/ml e 2 mg/ml respectivamente. Foram obtidos melhores resultados para bactérias Gram positivo comparativamente com as bactérias Gram negativo. Assim, podemos constatar que mesmo recorrendo a baixas concentrações (2 mg/ml) os resultados são muito promissores mesmo em bactérias Gram negativo com perfis de resistência elevados e relacionadas com as infeções associadas aos cuidados de Saúde (IACS) como a Pseudomonas aeruginosa e Acinetobacter baumannii

Antibacterial activity of Euterpe oieracea Mart. seeds against clinical isolates

Introduction: The use of antibiotics – including the over- and misuse – in human and veterinary practices selected for resistant pathogens led to their emergence and dissemination along with the transmission of resistant bacteria [1]. Due to this problem, there is a need to investigate new strategies to reverse this tendency in order to achieve the appropriate and effective treatment against infections. Aims: The present work aimed to evaluate the antibacterial activity of an aqueous extract prepared from Euterpe Oleracea Mart. (açai) seeds (originated from Brazil [2]), against clinical isolates from “Centro Hospitalar de Trás-os-Montes e Alto Douro- Unidade de Vila Real”, with high resistance profiles to different antibiotics. Material and Methods: The minimal inhibitory concentrations (MIC) of the growth of Gram-positive and Gram-negative bacteria were determined by the colorimetric assay based on the use of p-iodonitrotetrazolium chloride (INT) dye, after application of the microdilution method. Results and discussion: The açaí aqueous extract showed antimicrobial activity against all the tested Gram-positive bacteria. The lowest MICs (0.25 mg/ml) were obtained against Methicillin Susceptible Staphylococcus aureus (MSSA) and Methicillin Resistant S. aureus (MRSA), followed by the MIC 0.5 mg/ml correspondent to Streptococcus agalactiae and Enterococcus faecalis. Regarding the inhibition of the growth of Gram-negative bacteria, the extract was active against Morganella morganii, Pseudomonas aeruginosa and Acinetobacter baumannii with MICs 1 mg/ml e 2 mg/ml, respectively. The results were better for Gram-positive bacteria in comparison with Gram-negative bacteria. Conclusion: However, even at low concentration (2 mg/ml) the results are very promising for Gram-negative bacteria with high resistance profiles and commonly related with health care-associated infections, namely Pseudomonas aeruginosa and Acinetobacter baumannii

Proteasome and heat shock protein 70 (HSP70) inhibitors as therapeutic alternative in multiple myeloma

HSP70 connects multiple signaling pathways that work synergistically to protect tumor cells from death by proteotoxic stress and represents a possible target to establish a new approach for multiple myeloma treatment. Therefore, bioluminescent cell lines RPMI8226-LUC-PURO and U266-LUC-PURO were treated with HSP70 (VER155008) and/or proteasome (bortezomib) inhibitors and immunodeficient mice were used for subcutaneous xenograft models to evaluate tumor growth reduction and tumor growth inhibition after treatment. Bioluminescence imaging was used to follow tumor response. Treatment with bortezomib showed similar to 60% of late apoptosis in RPMI8226-LUC-PURO (without additional benefit of VER155008 in this cell line). However, U266-LUC-PURO showed similar to 60% of cell death after treatment with VER155008 (alone or with bortezomib). RPMI8226-LUC-PURO xenograft presented tumor reduction by bioluminescence imaging after treatment with bortezomib, VER155008 or drug combination compared to controls. Treatment with bortezomib, alone or combined with VER155008, showed inhibition of tumor growth assessed by bioluminescence imaging after one week in both RPMI8226-LUC-PURO and U266-LUC-PURO cell lines when compared to controls. In conclusion, our study shows that the combination of proteasome and HSP70 inhibitors induced cell death in tumor cells in vitro (late apoptosis induction) and in vivo (inhibition of tumor growth) with special benefit in U266-LUC-PURO, bearing 17p deletion.Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), BrazilFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil [2010/17668-6]Univ Fed Sao Paulo, UNIFESP, Dept Clin & Expt Oncol, Discipline Hematol & Hemotherapy, Sao Paulo, SP, BrazilUniv Sao Paulo, Fac Med, Canc Inst State Sao Paulo, Ctr Translat Invest Oncol, Sao Paulo, SP, BrazilUniv Fed Sao Paulo, UNIFESP, Dept Pathol, Sao Paulo, SP, BrazilUniv Fed Sao Paulo, UNIFESP, Dept Biochem, Sao Paulo, SP, BrazilUniv Fed Sao Paulo, UNIFESP, Dept Clin & Expt Oncol, Discipline Hematol & Hemotherapy, Sao Paulo, SP, BrazilUniv Fed Sao Paulo, UNIFESP, Dept Pathol, Sao Paulo, SP, BrazilUniv Fed Sao Paulo, UNIFESP, Dept Biochem, Sao Paulo, SP, BrazilFAPESP [2010/17668-6]Web of Scienc

Efficacy of azithromycin and miltefosine in experimental systemic pythiosis in immunosuppressed mice

We evaluated the efficacy of azithromycin (50 mg/kg, every 12 h [q12h] orally) and miltefosine (25 mg/kg, q24h orally) treatments in an experimental model of vascular/disseminated pythiosis in immunosuppressed mice. Azithromycin was the only treatment able to reduce mortality. The histopathological findings showed acute vascular inflammation, pathogen dissemination, necrotizing myositis, neuritis, and arteritis. The results suggest that azithromycin, but not miltefosine, may have clinical relevance in the treatment of vascular/disseminated pythiosis

The powerful in vitro bioactivity of Euterpe oleracea Mart. seeds and related phenolic compounds

The Euterpe oleracea Mart. (açaí) is a plant from the Amazon region, classified as "super fruit" because of its various functional properties. However, limited investigation has been performed on açaí by-products, such as seeds. Therefore, the aim of this work was to characterized the phenolic compounds of the aqueous extract of açaí seeds and further evaluate its bioactivity (antioxidant and cytotoxic activities. Only proanthocyanidins were detected, being a B-type (epi)catechin tetramer the most abundant; however, procyanidin trimmers were the most predominant form. Açaí seeds extract revealed a high antioxidant (EC50 ranging from 3.6 to 19.4 μg/mL) and cytotoxic activity, being more effective in the cervical carcinoma cell line (HeLa; GI50 = 18 μg/mL); it did not show toxicity for non-tumor cells. Açaí seeds are considered a waste and could have an added economic benefit, through the extraction of natural antioxidants, particularly proanthocyanidins, that could find applications in food and pharmaceutical industries.The authors are grateful to Foundation for Science and Technology (FCT, Portugal) for financial support to the research centre CIMO (strategic project PEst OE/AGR/UI0690/2011) and L. Barros researcher contract under “Programa Compromisso com Ciência - 2008”. The authors are also grateful to Jamil S. Oliveira by the initial discussions on the preparation of samples

CRIANÇA COM HIV/AIDS: PERCEPÇÃO DO TRATAMENTO ANTIRRETROVIRAL

Neste artigo, faz-se um recorte do estudo multicêntrico, realizado nos municípios de Porto Alegre e Santa Maria/RS, com o objetivo de desvelar a percepção e a vivência da criança quanto ao tratamento antirretroviral. Comabordagem qualitativa, o estudo foi realizado com sete crianças, com idade entre cinco e 10 anos de idade, no períodode 2006 a 2010, após aprovação pela Comissão Nacional de Ética em Pesquisa e pelos Comitês de Ética em pesquisa.A partir da análise temática, foram obtidos os resultados: Cotidiano medicamentoso da criança; Cuidado familialna adesão ao tratamento antirretroviral; Cuidado Profissional: percepção da criança com a infecção. Observou-seque as crianças enfrentam adversidades, conhecem e valorizam o tratamento apesar do movimento paradoxal derejeição/aceitação manifestados pela luta contra a síndrome

Oncoplastic breast consortium recommendations for mastectomy and whole breast reconstruction in the setting of post-mastectomy radiation therapy

Aim: Demand for nipple-and skin-sparing mastectomy (NSM/SSM) with immediate breast reconstruction (BR) has increased at the same time as indications for post-mastectomy radiation therapy (PMRT) have broadened. The aim of the Oncoplastic Breast Consortium initiative was to address relevant questions arising with this clinically challenging scenario. Methods: A large global panel of oncologic, oncoplastic and reconstructive breast surgeons, patient advocates and radiation oncologists developed recommendations for clinical practice in an iterative process based on the principles of Delphi methodology. Results: The panel agreed that surgical technique for NSM/SSM should not be formally modified when PMRT is planned with preference for autologous over implant-based BR due to lower risk of long-term complications and support for immediate and delayed-immediate reconstructive approaches. Nevertheless, it was strongly believed that PMRT is not an absolute contraindication for implant-based or other types of BR, but no specific recom-mendations regarding implant positioning, use of mesh or timing were made due to absence of high-quality evidence. The panel endorsed use of patient-reported outcomes in clinical practice. It was acknowledged that the shape and size of reconstructed breasts can hinder radiotherapy planning and attention to details of PMRT techniques is important in determining aesthetic outcomes after immediate BR. Conclusions: The panel endorsed the need for prospective, ideally randomised phase III studies and for surgical and radiation oncology teams to work together for determination of optimal sequencing and techniques for PMRT for each patient in the context of BRPeer reviewe